Home
About
Team
Careers
Products
CertOss Conduit
CognitOss Gel
LDGraft
Videos
News
Contact
Locate Bio
Home
About
Team
Advisory Board
Careers
Products
CertOss Conduit
CognitOss Gel
LDGraft
Videos
News
Resources
Contact
News
Locate Bio’s LDGraft Granted FDA Breakthrough Device Designation
18th May, 2023
Locate Bio Closes £10 million Funding Round
3rd September, 2021
Locate Bio’s Chondro3 Granted FDA Breakthrough Device Designation
24th February, 2021
CognitOss Granted FDA Breakthrough Device Designation
7th January, 2021
Locate Bio appoints Keith Valentine as the Non-Executive Chair of the Board of Directors
5th January, 2021
Locate Bio acquires complementary late stage orthobiologics assets
21st September, 2020
Locate Bio raises £2.25m for new spinal treatments
20th July, 2020
Locate Bio announces the appointment of John von Benecke as CEO
14th May, 2020
Locate Bio receives £2.0 million investment from Mercia and the MEIF to expand its cell and gene therapy pipeline
15th May, 2019
Locate Therapeutics announces name change to Locate Bio and new investment from Mercia Technologies PLC
16th October, 2018